Bioinformatic analysis performed using the UCSC Xena platform (https://xena.ucsc.edu/compare-tissue/), based on TCGA Breast Cancer (BRCA) cohort data (accessed on 28 March 2025), showed that PAX5 expression does not influence overall survival in breast cancer patients (Figure 1A). Here, PAX5 is linked to breast carcinoma.